| Item 1. | |
| (a) | Name of issuer:
Biohaven Ltd. |
| (b) | Address of issuer's principal executive offices:
c/o Biohaven Pharmaceuticals, Inc. 215 Church Street, New Haven, Connecticut 06510 |
| Item 2. | |
| (a) | Name of person filing:
Suvretta Capital Management, LLC - Delaware
Averill Master Fund, Ltd. - Cayman Islands
Aaron Cowen - U.S.A. |
| (b) | Address or principal business office or, if none, residence:
Suvretta Capital Management, LLC:
540 Madison Avenue, 7th Floor
New York, New York 10022
United States of America
Averill Master Fund, Ltd.:
c/o Maples Corporate Services Limited
P.O. Box 309
Ugland House
Grand Cayman KY1-1104
Cayman Islands
Aaron Cowen:
c/o Suvretta Capital Management, LLC
540 Madison Avenue, 7th Floor
New York, New York 10022 |
| (c) | Citizenship:
Suvretta Capital Management, LLC - Delaware
Averill Master Fund, Ltd. - Cayman Islands
Aaron Cowen - U.S.A. |
| (d) | Title of class of securities:
Common Shares, no par value |
| (e) | CUSIP No.:
G1110E107 |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
Suvretta Capital Management, LLC - 10,286,937
Averill Master Fund, Ltd. - 8,800,438
Aaron Cowen - 10,286,937 |
| (b) | Percent of class:
Suvretta Capital Management, LLC - 7.8%
Averill Master Fund, Ltd. - 6.6%
Aaron Cowen - 7.8% |
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
Suvretta Capital Management, LLC - 0
Averill Master Fund, Ltd. - 0
Aaron Cowen - 0
|
| | (ii) Shared power to vote or to direct the vote:
Suvretta Capital Management, LLC - 10,286,937
Averill Master Fund, Ltd. - 8,800,438
Aaron Cowen - 10,286,937
|
| | (iii) Sole power to dispose or to direct the disposition of:
Suvretta Capital Management, LLC - 0
Averill Master Fund, Ltd. - 0
Aaron Cowen - 0
|
| | (iv) Shared power to dispose or to direct the disposition of:
Suvretta Capital Management, LLC - 10,286,937
Averill Master Fund, Ltd. - 8,800,438
Aaron Cowen - 10,286,937
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| |
Not Applicable
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G Amendment No. 3 are directly owned by advisory clients of Suvretta Capital Management, LLC. None of those advisory clients, other than Averill Master Fund, Ltd., may be deemed to beneficially own more than 5% of the Common Shares, no par value. |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See Exhibit B attached hereto. |
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|
